Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03263195 · ClinicalTrials.gov registry record

Prospective Cohort Study of HIV and Zika in Infants and Pregnancy

A clinical trial of HIV and Pregnant Women, sponsored by Westat.

Completed
Registry status
395
Enrollment target
11
Study locations

NCT03263195 is a study of HIV and Pregnant Women that has completed, run by Westat. The registered enrollment target is 395 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (10% lower). The trial reports 11 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03263195, a study of HIV and Pregnant Women, has completed, sponsored by Westat.

COMPLETED
Registry status
395 participants
Enrollment target
11
Study locations

Study Summary

The purpose of this study is to compare the incidence of Zika virus (ZIKV) infection among pregnant women with and without Human Immunodeficiency Virus (HIV) infection and to determine the risk of adverse maternal and child outcomes associated with ZIKV/HIV co-infection across clinical sites in the continental United States (U.S.), Puerto Rico (P.R.) and Brazil.

Study Locations (11)

Other

  • Hospital Federal dos Servidores do Estado NICHD CRS - Rio de Janeiro
  • Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS - Rio de Janeiro
  • Hosp. Geral De Nova Igaucu Brazil NICHD CRS - Rio de Janeiro
  • University of Sao Paulo at Riberaio Preto Brazil - São Paulo
  • University of Puerto Rico Pediatrics HIV/AIDS Research Program - San Juan
  • San Juan City Hosp. PR NICHD CRS - San Juan

Texas

  • Baylor College of Medicine; Texas Children's Hospital - Houston
  • Baylor College of Medicine - Houston

Florida

  • University of Miami Pediatric/Prenatal HIV/AIDS - Miami

New York

  • Bronx-Lebanon Hospital Center NICHD CRS - The Bronx

Minas Gerais

  • SOM Federal University Minas Gerais Brazil NICHD CRS - Belo Horizonte

Trial Details

FieldValue
Enrollment Target 395 participants
Start Date 2017-08-23
Est. Completion 2020-09-30

Sponsor

Westat

13 total trials

What the Registry Record Tells You About NCT03263195

The ClinicalTrials.gov registry entry for NCT03263195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (10% lower). The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 0 interventions.

NCT03263195 reports 11 study locations spanning 5 distinct geographic areas - top geographies include Other, Texas, Florida.

Frequently Asked Questions

What is clinical trial NCT03263195 about?

NCT03263195 is a clinical study titled "Prospective Cohort Study of HIV and Zika in Infants and Pregnancy". The purpose of this study is to compare the incidence of Zika virus (ZIKV) infection among pregnant women with and without Human Immunodeficiency Virus (HIV) infection and to determine the risk of adverse maternal and child outcomes associated with ZIKV/HIV co-infection across clinical sites in the ...

What is the current status of trial NCT03263195?

This trial is currently completed. The enrollment target is 395 participants. The study started on 2017-08-23. Estimated completion is 2020-09-30.

What conditions does trial NCT03263195 study?

This clinical trial studies the following conditions: HIV, Pregnant Women, Zika Virus.

Who is sponsoring clinical trial NCT03263195?

This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03263195 being conducted?

This trial has 11 study locations across Florida, New York, Texas, Minas Gerais. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.